Syllabus
L: Musculoskeletal System
- L2i / 14B07 : Outline mechanisms that potentiate the action of NDMR and give examples 15%
- L2i / 16A12 / 14A09: Factors which influence speed of neuromuscular blockade
- L2i / 18A10 : Outline the advantages and diasdvantages of SUX
- L2i / 18A14 / 15A21 : Classify Anticholinesterase drugs according to chemical interaction with an example of each (30). Outline the PD effects of anticholinesterase drugs and their clinical indications (70)
- L2i / 18B13: Compare and contrast rocuronium and cisatracurium
- L2i / 20B10: Describe the pharmacology of suxamethonium
- L2i / 21A06: Describe the pharmacology of vecuronium, including factors that prolong its action of neuromuscular blockade
- L2i / 22A13: Compare and contrast the pharmacology of Suxamethonium and Rocuronium
- L2i / 23A19: Describe factors that prolong the action of neuromuscular blocking agents (60% marks). Outline the pharmacokinetics and pharmacodynamics of vecuronium (40% marks)
- L2i: Cholinesterases
- L2i: Pharmacology of NDMR